The FDA assessed the safety and performance of atidarsagene autotemcel determined by knowledge from 37 young children who obtained atidarsagene autotemcel in two one-arm, open-label medical trials and in an expanded obtain program.[seven] Young children who obtained procedure with atidarsagene autot